Company Monitoring Page for MannKind

latest headlines for company on cafepharma

2011 Drugmaker M&A Targets
Motley Fool
Fri, 12/31/10 - 10:00 am
Tags:
M&A, Pfizer, Merck, Genzyme, Sanofi, JNJ, Crucell, ONYX Pharmaceuticals, Bayer, Momenta, Novartis, GSK, Human Genome Sciences, Vertex Pharmaceuticals, MannKind, Vivus, Savient
FDA Delay of MannKind's Inhaled Insulin Is Mostly Positive News
Seeking Alpha
Thu, 12/30/10 - 11:12 am
Tags:
MannKind, FDA, Afrezza, inhaled insulin
FDA Delay Could Be Very Bad Omen For MannKind
Forbes
Tue, 12/28/10 - 03:59 pm
Tags:
FDA, MannKind, inhaled insulin, Afrezza
MannKind Says FDA Will Take Another Four Weeks on Insulin Decision
WSJ Online
Tue, 12/28/10 - 01:08 pm
Tags:
FDA, inhaled insulin, MannKind, Afrezza
Will the FDA Be Kind to MannKind?
Motley Fool
Wed, 12/22/10 - 04:36 pm
Tags:
FDA, MannKind, inhaled insulin, Afrezza
Three Upcoming Make-or-Break Biotech Approvals
Seeking Alpha
Sun, 12/19/10 - 11:22 am
Tags:
Vertex Pharmaceuticals, Telaprevir, Merck, hepatitis C, cystic fibrosis, Human Genome Sciences, Benlysta, lupus, MannKind, Afrezza, inhaled insulin
MannKind Shares Plunged: What You Need to Know
Motley Fool
Thu, 12/16/10 - 12:48 pm
Tags:
MannKind, Afrezza, insulin
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
Tags:
MannKind, Afrezza, Alimera, pSivida, Seattle Genetics, brentuximab vedotin, Illuvien, AstraZeneca, Zictifa, Clinical Data, Vilazodone, Orexigen, Contrave, Bristol-Myers Squibb, Yervoy, Pfizer, Protalix BioTherapeutics, UPLYSO, Xiafaxan, Salix, Human Genome Sciences, Benlysta, Dendreon, Provenge, InterMune, Esbriet, Cell Therapeutics, pixantrone, Forest Labs, Daxas, MELA Sciences, MelaFind, XenoPort, GSK, Horizant, Spectrum Pharmaceuticals, Fusilev, Adventrx, Vertex Pharmaceuticals, Telaprevir
Neutral on MannKind
Yahoo/Zacks
Sat, 12/11/10 - 11:39 am
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
Clearing Up the Uncertainty Around MannKind’s Afrezza
Seeking Alpha
Wed, 12/8/10 - 10:01 am
Tags:
MannKind, inhaled insulin, Afrezza
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Tags:
Delcath, Arena Pharmaceuticals, RXi Pharmaceuticals, Cell Therapeutics, Amgen, Incyte, Celgene, Corcept Therapeutics, Affymax, Targacept, Exelixis, Orexigen, ONYX Pharmaceuticals, Seattle Genetics, MannKind, Alimera, AstraZeneca, Human Genome Sciences
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
Tags:
biotech, R&D, Amgen, Biogen Idec, Gilead Sciences, Genzyme, Celgene, Kyowa Hakko Kirin, Vertex Pharmaceuticals, Life Technologies, CSL, Amylin, Genmab, Cubist Pharmaceuticals, MannKind, companies, Merial
A Small Step Back for MannKind?
Seeking Alpha
Sun, 11/7/10 - 11:29 am
Tags:
MannKind, inhaled insulin
Is MannKind a Bad News Buy?
Motley Fool
Sat, 11/6/10 - 12:59 pm
Tags:
MannKind, inhaled insulin, Afrezza, diabetes
MannKind Falls After Lawsuit Alleges Unlawful Clinical Trial Conduct
Bloomberg
Thu, 11/4/10 - 10:00 pm
Tags:
MannKind, lawsuits, diabetes, fraud, Afrezza
MannKind Accused of Data Fraud Coverup
TheStreet.com
Thu, 11/4/10 - 11:33 am
Tags:
MannKind, fraud, Afrezza, inhaled insulin, diabetes
Loss at MNKD Wider than Expected
Yahoo/Zacks.com
Mon, 11/1/10 - 11:25 am
Tags:
MannKind, earnings, Pfizer
[video] For All MannKind?
CNBC
Fri, 10/15/10 - 10:38 am
Tags:
inhaled insulin, MannKind, Afrezza
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Tags:
Linjeta, Biodel, Afrezza, MannKind, FDA, Benlysta, Human Genome, GSK, Bydureon, Eli Lilly, Amylin, Alkermes, Brilinta, AstraZeneca, Pradaxa, Boehringer Ingelheim, Qnexa, Vivus, Contrave, Orexigen, ipilimumab, Bristol-Myers Squibb, Merck KGaA, cladribine
Biodel's Linjeta Should Overcome the Usual FDA Approval Hurdles
Seeking Alpha
Wed, 09/15/10 - 10:46 am
Tags:
FDA, Biodel, Linjeta, diabetes, MannKind, inhaled insulin, Afrezza, insulin injectables

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.